Work

Inhibition of the Raf–MEK1/2–ERK1/2 Signaling Pathway, Bcl-xL Down-Regulation, and Chemosensitization of Non-Hodgkin’s Lymphoma B Cells by Rituximab

Year: 2004

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.can-03-3500

Authors: Ali R. Jazirehi, Mario I. Vega, Devasis Chatterjee, Lee Goodglick, Benjamin Bonavida

Institutions: Brown University, Rhode Island Hospital, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2068033067

FWCI: 8.847

Cites: 46

Cited by: 188

Related to: 10